Introduction: Serological antibodies have been associated with complicated disease course
in Crohn's disease (CD), including the need for surgery. Aim: The aim of this study was to …

Abstract Background and Aims Non-invasive biomarkers in sera of patients with
inflammatory bowel disease [IBD] are not currently available for rapidly and accurately …

The chronic inflammatory bowel diseases (IBD), Crohn's disease (CD) and ulcerative colitis
(UC), encompass a wide spectrum of diseases, characterized by both intestinal and extra …

Biomarkers to guide clinical decision making at diagnosis of inflammatory bowel disease
[IBD] are urgently needed. We investigated a composite serum N-glycomic biomarker to …

BACKGROUND It has been suggested that apolipoprotein E (APOE) polymorphisms are
associated with the risk of developing inflammatory bowel disease (IBD) and the early age of …

Although inflammatory bowel disease (IBD) is found worldwide, the majority of studies have
focused on white populations in North America and Europe. The incidence (or number of …

Objective Most patients with Crohn's disease (CD) are diagnosed with the uncomplicated
inflammatory form of the disease (Montreal stage B1). However, the majority of them will …

The disease course of inflammatory bowel disease (IBD) is highly heterogeneous and
unpredictable. The risk of fistulae formation and stricturing complications that lead to surgery …

Background The aim was to study the association between six serological markers and
Crohn's disease (CD) activity at an inflammatory bowel disease (IBD) referral center …

Stricture formation is a common complication of Crohn's disease, occurring in approximately
one third of all patients with this condition. While the traditional management of such …